You may also like
Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome: How do we Expand Capacity in the COVID-19 Era?
Despite advances in medical technology, the mortality rate for severe acute respiratory distress syndrome (ARDS) remains high at around 40%. In recent years, multiple studies, systematic reviews, and meta-analyses, including the study in this issue of Heart, Lung and Circulation published by Wang and colleagues, have indicated that treatment with veno-venous extracorporeal membrane oxygenation (VV-ECMO) may be associated with better outcomes in severe ARDS than conventional mechanical ventilation.
7 min read
Clinical Outcomes at One Year Following Transcatheter Aortic Valve Replacement
This article updates the previous report of 30-day outcomes and present 1-year outcomes following transcatheter aortic valve replacement (TAVR) in the United States.
1 min read
Argatroban as an Alternative to Heparin in Extracorporeal Membrane Oxygenation Circuits
These results suggest that argatroban may be more efficacious than heparin for anticoagulation in ECMO.
1 min read